DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Carbone DP. et al.
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
N Engl J Med 2017;
376 (25) 2415-2426
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.